International Clinical Trial: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vericiguat in Hospitalized Patients with Heart Failure and Low Blood Pressure

Geneva, May 29 -- International Clinical Trials Registry received information related to the study (ChiCTR2600125254) titled 'A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vericiguat in Hospitalized Patients with Heart Failure and Low Blood Pressure' on May 22.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: Chinese Academy of Medical Sciences Fuwai Hospital

Condition: Heart Failure and Low Blood Pressure

Intervention: Experimental group:Administer vericiguat (starting at 5 mg/day and titrating to 10 mg/day or the maximum tolerated dose).

Recruitment Status: Not Recruiting

Phase: 4

Date of First Enrollment: 2026-06-01

Target Sample Size: Experimental gro...